Nms Pharmaceuticals, Inc.

Nms Pharmaceuticals, Inc. — FDA 510(k) Submissions

Nms Pharmaceuticals, Inc. has submitted 9 FDA 510(k) premarket notifications since 1984, of which 8 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Luteinizing Hormone, Visual, Pregnancy Hcg, Prescription Use, Reagent, Occult Blood, Ige, Antigen, Antiserum, Control, Radioimmunoassay, Estriol . Use the specialty filter in the sidebar to narrow results.